Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W HUMPHREY

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Archives of Biochemistry and Biophysics|September 10, 1995
Inhibition of the human immunodeficiency virus-1 protease and human immunodeficiency virus-1 replication by bathocuproine disulfonic acid Cu1+D A Davis, A A Branca, A J Pallenberg, et al.
Nature Communications|June 17, 2022
Regional and seasonal partitioning of water and temperature controls on global land carbon uptake variabilityKai Wang, Ana Bastos, Philippe Ciais, et al.
Journal of the National Cancer Institute|July 19, 2011
Opportunities and challenges in the development of experimental drug combinations for cancerRachel W Humphrey, Laura M Brockway-Lunardi, David T Bonk, et al.
Blood|July 1, 1996
Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugsR W Humphrey, T R O'Brien, F M Newcomb, et al.
Antiviral Research|May 13, 1999
A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infectionR W Humphrey, K M Wyvill, B Y Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcomaL Welles, M W Saville, J Lietzau, et al.
Developmental Biology|September 13, 2006
A genomic view of the sea urchin nervous systemR D Burke, L M Angerer, M R Elphick, et al.
Journal for Immunotherapy of Cancer|September 29, 2022
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)Michael B Atkins, Hamzah Abu-Sbeih, Paolo A Ascierto, et al.
Journal for Immunotherapy of Cancer|April 3, 2020
Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance TaskforceHarriet M Kluger, Hussein A Tawbi, Maria L Ascierto, et al.
Science (New York, N.Y.)|November 11, 2006
The genome of the sea urchin Strongylocentrotus purpuratus, Erica Sodergren, George M Weinstock, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Archives of Biochemistry and Biophysics|September 10, 1995
Inhibition of the human immunodeficiency virus-1 protease and human immunodeficiency virus-1 replication by bathocuproine disulfonic acid Cu1+D A Davis, A A Branca, A J Pallenberg, et al.
Nature Communications|June 17, 2022
Regional and seasonal partitioning of water and temperature controls on global land carbon uptake variabilityKai Wang, Ana Bastos, Philippe Ciais, et al.
Journal of the National Cancer Institute|July 19, 2011
Opportunities and challenges in the development of experimental drug combinations for cancerRachel W Humphrey, Laura M Brockway-Lunardi, David T Bonk, et al.
Blood|July 1, 1996
Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugsR W Humphrey, T R O'Brien, F M Newcomb, et al.
Antiviral Research|May 13, 1999
A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infectionR W Humphrey, K M Wyvill, B Y Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcomaL Welles, M W Saville, J Lietzau, et al.
Developmental Biology|September 13, 2006
A genomic view of the sea urchin nervous systemR D Burke, L M Angerer, M R Elphick, et al.
Journal for Immunotherapy of Cancer|September 29, 2022
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)Michael B Atkins, Hamzah Abu-Sbeih, Paolo A Ascierto, et al.
Journal for Immunotherapy of Cancer|April 3, 2020
Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance TaskforceHarriet M Kluger, Hussein A Tawbi, Maria L Ascierto, et al.
Science (New York, N.Y.)|November 11, 2006
The genome of the sea urchin Strongylocentrotus purpuratus, Erica Sodergren, George M Weinstock, et al.
Pageof 9